Free Trial
Fall Lock-In Sale! MarketBeat All Access, $149 a Year for Life
Lock In $149
Claim MarketBeat All Access Sale Promotion

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DaVita Inc. stock logo
DVA
DaVita
$183.55
-1.4%
$180.60
$101.00
▼
$247.49
$11.87B0.8634,743 shs618,064 shs
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$22.67
+2.0%
$22.46
$20.02
▼
$27.40
$11.94B0.741.28 million shs733,455 shs
Hinge Health Inc. stock logo
HNGE
Hinge Health
$111.47
+1.4%
$95.56
$30.08
▼
$113.48
$8.87B1.371.86 million shs1.56 million shs
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
$22.41
-2.1%
$20.82
$18.92
▼
$28.82
$2.92B0.81.30 million shs669,353 shs
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DaVita Inc. stock logo
DVA
DaVita
-1.64%-1.93%+0.26%-22.05%+42.37%
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
+2.03%+2.30%+1.03%-7.78%-17.31%
Hinge Health Inc. stock logo
HNGE
Hinge Health
+1.18%+12.29%+20.81%+50.21%+129.28%
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
-2.10%-0.49%+17.33%-12.12%-13.71%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DaVita Inc. stock logo
DVA
DaVita
$183.55
-1.4%
$180.60
$101.00
▼
$247.49
$11.87B0.8634,743 shs618,064 shs
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$22.67
+2.0%
$22.46
$20.02
▼
$27.40
$11.94B0.741.28 million shs733,455 shs
Hinge Health Inc. stock logo
HNGE
Hinge Health
$111.47
+1.4%
$95.56
$30.08
▼
$113.48
$8.87B1.371.86 million shs1.56 million shs
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
$22.41
-2.1%
$20.82
$18.92
▼
$28.82
$2.92B0.81.30 million shs669,353 shs
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DaVita Inc. stock logo
DVA
DaVita
-1.64%-1.93%+0.26%-22.05%+42.37%
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
+2.03%+2.30%+1.03%-7.78%-17.31%
Hinge Health Inc. stock logo
HNGE
Hinge Health
+1.18%+12.29%+20.81%+50.21%+129.28%
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
-2.10%-0.49%+17.33%-12.12%-13.71%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
DaVita Inc. stock logo
DVA
DaVita
2.57
Moderate Buy$233.4327.18% Upside
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
1.64
Reduce$23.433.35% Upside
Hinge Health Inc. stock logo
HNGE
Hinge Health
2.89
Moderate Buy$107.00-4.01% Downside
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
2.79
Moderate Buy$31.0038.33% Upside

Current Analyst Ratings Breakdown

Latest PRVA, FMS, DVA, and HNGE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/21/2026
DaVita Inc. stock logo
DVA
DaVita
Reiterated RatingBuy
10/16/2026
Hinge Health Inc. stock logo
HNGE
Hinge Health
Boost Price TargetOverweight$125.00 ➝ $140.00
10/15/2026
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
DowngradeHold ➝ Strong Sell
10/12/2026
Hinge Health Inc. stock logo
HNGE
Hinge Health
Boost Price TargetOverweight$100.00 ➝ $110.00
10/12/2026
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
Lower Price TargetHold$25.00 ➝ $24.00
10/9/2026
DaVita Inc. stock logo
DVA
DaVita
UpgradeHold (C+) ➝ Buy (B-)
10/8/2026
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
UpgradeHold (C) ➝ Hold (C+)
10/8/2026
Hinge Health Inc. stock logo
HNGE
Hinge Health
DowngradeHold (C) ➝ Hold (C-)
9/30/2026
Hinge Health Inc. stock logo
HNGE
Hinge Health
Boost Price TargetBuy$97.00 ➝ $115.00
9/29/2026
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
Reiterated RatingHold (C)
9/29/2026
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
Set Price Target$24.00
(Data available from 10/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
DaVita Inc. stock logo
DVA
DaVita
$13.64B0.86$21.42 per share8.57($5.29) per share-34.70
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$19.43B0.63$5.68 per share3.99$28.93 per share0.78
Hinge Health Inc. stock logo
HNGE
Hinge Health
$720.06M12.49N/AN/A$2.26 per share49.32
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
$2.12B1.35$0.26 per share85.75$6.43 per share3.49
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
DaVita Inc. stock logo
DVA
DaVita
$746.80M$12.2215.0210.640.486.05%-217.63%5.07%10/29/2026 (Estimated)
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$1.11B$1.9311.749.815.174.83%9.28%4.16%11/3/2026 (Estimated)
Hinge Health Inc. stock logo
HNGE
Hinge Health
-$528.26M$1.2887.0981.96N/A15.15%51.60%14.16%11/2/2026 (Confirmed)
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
$22.92M$0.21106.7254.66N/A1.19%3.52%2.00%11/5/2026 (Estimated)

Latest PRVA, FMS, DVA, and HNGE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/5/2026Q3 2026
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
$0.0906N/AN/AN/A$610.74 millionN/A
11/3/2026Q3 2026
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$0.6510N/AN/AN/A$5.54 billionN/A
10/29/2026Q3 2026
DaVita Inc. stock logo
DVA
DaVita
$3.57N/AN/AN/A$3.52 billionN/A
8/6/2026Q2 2026
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
$0.0674$0.19+$0.1226$0.07$597.33 million$632.63 million
8/4/2026Q2 2026
DaVita Inc. stock logo
DVA
DaVita
$3.88$4.02+$0.14$4.02$3.50 billion$3.55 billion
8/4/2026Q2 2026
Hinge Health Inc. stock logo
HNGE
Hinge Health
$0.28$0.59+$0.31$0.52N/A$212.82 million
8/3/2026Q2 2026
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$0.6160$0.66+$0.0440$0.46$5.48 billion$5.55 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
DaVita Inc. stock logo
DVA
DaVita
N/AN/AN/AN/AN/A
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$0.612.69%+2.66%31.61%N/A
Hinge Health Inc. stock logo
HNGE
Hinge Health
N/AN/AN/AN/AN/A
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
DaVita Inc. stock logo
DVA
DaVita
N/A
1.47
1.41
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
0.43
1.07
0.75
Hinge Health Inc. stock logo
HNGE
Hinge Health
N/A
1.34
1.30
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
N/A
1.62
1.62

Institutional Ownership

CompanyInstitutional Ownership
DaVita Inc. stock logo
DVA
DaVita
90.12%
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
8.37%
Hinge Health Inc. stock logo
HNGE
Hinge Health
N/A
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
94.48%

Insider Ownership

CompanyInsider Ownership
DaVita Inc. stock logo
DVA
DaVita
1.90%
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
N/A
Hinge Health Inc. stock logo
HNGE
Hinge Health
18.92%
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
5.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
DaVita Inc. stock logo
DVA
DaVita
78,00063.80 million62.59 millionOptionable
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
1,488537.13 millionN/AOptionable
Hinge Health Inc. stock logo
HNGE
Hinge Health
1,43780.69 million65.43 millionOptionable
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
1,226127.73 million120.45 millionOptionable

Recent News About These Companies

Privia Health stock reports strong Q2 growth and guidance
Privia Health Group Inc (PRVA)
Why Privia Health Group (PRVA) Is Getting Attention Now
Truist Financial Remains a Buy on Privia Health Group (PRVA)
Privia Health Group (PRVA) Gets a Buy from Citi
Evercore ISI Remains a Buy on Privia Health Group (PRVA)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
DaVita stock logo

DaVita NYSE:DVA

$183.55 -2.55 (-1.37%)
Closing price 10/23/2026 03:59 PM Eastern
Extended Trading
$182.30 -1.24 (-0.68%)
As of 10/23/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Fresenius Medical Care AG & Co. KGaA stock logo

Fresenius Medical Care AG & Co. KGaA NYSE:FMS

$22.66 +0.44 (+1.96%)
Closing price 10/23/2026 03:59 PM Eastern
Extended Trading
$22.68 +0.01 (+0.04%)
As of 10/23/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Hinge Health stock logo

Hinge Health NYSE:HNGE

$111.47 +1.54 (+1.40%)
Closing price 10/23/2026 03:59 PM Eastern
Extended Trading
$112.50 +1.03 (+0.92%)
As of 10/23/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients. We have designed our platform to address a broad spectrum of MSK care—from acute injury, to chronic pain, to post-surgical rehabilitation. Members receive personalized and largely automated MSK care through our AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device, all designed and monitored by our AI-supported care team of licensed physical therapists, physicians, and board-certified health coaches. Our platform can improve pain and function and reduce the need for surgeries, all while driving health equity by allowing members to engage in their exercise therapy sessions from anywhere and embrace movement as a way of life. There is no shortage of new technologies in the healthcare industry, yet the cost of care continues to rise. In other industries, the launch of new technologies has generally improved end-user experiences and lowered costs. In healthcare, however, new technologies have not always been successful in lowering the cost of care or improving clinical outcomes. We believe there are two key reasons for healthcare’s idiosyncratic response to technology: • Automating most aspects of care is difficult because so many healthcare interventions involve unstructured physical tasks. • The current framework for healthcare reimbursement has specific pathways to pay for care, which means new technologies are constrained to deliver within this framework. At Hinge Health, we have taken these challenges head-on. To address the automation of care, we have weaved together AI-enabled capabilities - such as our AI-powered motion tracking technology, TrueMotion, our proprietary FDA-cleared wearable device, Enso, and our AI-supported care team - to deliver scalable and personalized MSK care. According to our estimates based on data from 2024, our platform reduced the number of human care team hours associated with traditional physical therapy by approximately 95%. We have done this while improving our high member satisfaction over time. To address healthcare reimbursement constraints, we developed novel billing methods for our innovative technology by both directly selling to employers while also partnering with health plans, pharmacy benefit managers (“PBMs”), third-party administrators (“TPAs”), and other ecosystem entities to efficiently provide our platform to clients and members. While the MSK market is massive, existing solutions have fallen short as they are often expensive, ineffective, inconvenient to access, and delivered in a one-to-one or few-to-one care setting. Effective MSK care should be engaging, easy to use, and accessible anytime, anywhere. We developed Hinge Health to be simple and accessible, complete, personalized, and scalable. • Simple and accessible: We provide members access to our platform at no direct cost to them and without a copay or deductible. Members can access our broad spectrum of MSK care through a single on-demand app, designed to provide an engaging, seamless, and convenient digital experience whenever and wherever the member chooses. Potential members can complete a simple intake form, download the app, and start exercises soon thereafter. During the year ended December 31, 2024, approximately 64% of members were onboarded on the same day they completed their intake form, and approximately 75% of members were onboarded within the first week. • Complete: Our platform offers a wide range of support with multiple programs across many affected areas to provide a continuum of care from prevention to treatment of acute injury and chronic pain, as well as surgery decision support and post-surgical recovery. We also offer non-addictive and non-invasive pain relief via electrostimulation through our proprietary FDA-cleared wearable device, Enso, that is seamlessly integrated into our platform. • Personalized: Our platform delivers smarter care through AI and machine learning. Our AI model is trained on a large, proprietary MSK data set, and our technology is continuously learning and improving as each new member enrolls and engages with our programs, which creates a positive feedback loop. As of March 31, 2025, we had treated over one million members and our programs had tracked over 74 million activity sessions and 32 million member-reported outcome logs. We focus on personalization to keep members moving: from customized care plans to real-time in-app exercise feedback based on the member’s input and our proprietary motion tracking technology. • Scalable: Our AI-powered motion tracking technology, TrueMotion, allows us to deliver scalable and largely automated care. According to our estimates based on data from 2024, our platform reduced the number of human care team hours associated with traditional physical therapy by approximately 95%. While most of our programs provide members with access to a dedicated care team, our technology automates most aspects of care delivery while allowing our members to progress through their exercise therapy sessions on their own time. We have developed an efficient go-to-market model by working directly with our partners and clients. We seek to be the best solution on the market, the most validated solution on the market, and the easiest to buy. Our clients are primarily self-insured employers and include many of the nation’s leading enterprises across a broad range of industries and sizes. Within this segment, we also serve many public sector self-insured employers, such as state and local city governments and labor unions. In most instances, we partner with clients’ health plans, TPAs, PBMs, or other ecosystem entities to reduce the friction of contracting, procurement, security and IT reviews, onboarding, and billing. We are also in the early stages of expanding to serve health plans’ fully-insured and Medicare Advantage populations and federal insurance plans. As of December 31, 2024, we had approximately 20 million contracted lives across more than 2,250 clients. We had active client agreements with 49% of the Fortune 100 companies and 42% of the Fortune 500 companies, as of December 31, 2024. Despite this progress, our current contracted lives only represent 5% of our total addressable market. We believe that we grow efficiently because of our scalable, repeatable go-to-market model. We sell through our direct sales force and our partners. Once we contract with a client, we are most often the sole digital MSK care provider offered to their contracted lives. Our average contract term is three years. For the term of each contract, we are able to enroll, engage, and re-engage the client’s eligible lives, driving a recurring, repeatable revenue model, which is demonstrated in our net dollar retention of 117% as of December 31, 2024. Our 12-month client retention rate was 98% as of December 31, 2024. Additionally, we have a high level of client satisfaction, as shown by our client net promoter score (“NPS”) of 87 as of October 31, 2024. We also invested early in building our partner network. As of March 31, 2025, we had over 50 partners. Our partners include the five largest national health plans by self-insured lives, and the top three PBMs by market share. As of that date, we had retained 100% of our partners that we chose to work with since inception, excluding partners who were acquired. We have experienced significant growth since our inception, with a recurring revenue business model. As of December 31, 2024, we had over 532,000 members and more than 2,250 clients, compared to approximately 371,000 members and approximately 1,650 clients as of December 31, 2023. Our principal executive offices are located in San Francisco, California.

Privia Health Group stock logo

Privia Health Group NASDAQ:PRVA

$22.41 -0.48 (-2.10%)
Closing price 10/23/2026 04:00 PM Eastern
Extended Trading
$22.42 +0.01 (+0.04%)
As of 10/23/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.